Sphingolipidoses in Morocco: Chemical profiling for an affordable and rapid diagnosis strategy.


Journal

Prostaglandins & other lipid mediators
ISSN: 1098-8823
Titre abrégé: Prostaglandins Other Lipid Mediat
Pays: United States
ID NLM: 9808648

Informations de publication

Date de publication:
10 2023
Historique:
received: 27 02 2023
revised: 28 05 2023
accepted: 03 06 2023
medline: 11 9 2023
pubmed: 10 6 2023
entrez: 9 6 2023
Statut: ppublish

Résumé

Sphingolipidoses are a group of metabolic diseases in which lysosomal hydrolases dysfunction disrupt normal sphingolipids' metabolism, leading to excess accumulation in cellular compartments and excretion in urine. These pathologies represent a significant burden among Moroccan population, for which an easy access to enzymatic assays and genetic tests is not guaranteed. Parallel analytical methods thus have to be developed for preliminary screening. In this study, 107 patients were addressed to the metabolic platform of the Marrakesh Faculty of Medicine for diagnosis confirmation. Thin-Layer Chromatography was used as a first step to perform chemical profiling of the patients' urinary lipids, allowing 36% of the patients to be efficiently oriented towards the adequate enzymatic assay. UPLC-MS/MS analyses of urinary sulfatides excreted in urines patient had been used to control the reliability of TLC analysis and to obtain more accurate information related to the sulfatides isoforms. This analytical process combining TLC with UPLC-MS/MS has enabled rapid and appropriate patient management in a reduced time and with reduced resources.

Identifiants

pubmed: 37295489
pii: S1098-8823(23)00048-5
doi: 10.1016/j.prostaglandins.2023.106751
pii:
doi:

Substances chimiques

Sulfoglycosphingolipids 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

106751

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that there are no competing interests associated with the manuscript.

Auteurs

M Hammoud (M)

Metabolic platform, Biochemistry Laboratory, Team for Childhood, Health and Development, Faculty of Medicine, Cadi Ayyad University, B.P. 7010, Marrakesh, Morocco; Moroccan Association for Inherited Metabolic Diseases, Morocco.

A M S Rodrigues (AMS)

Sorbonne Université, CNRS, Laboratoire de Biodiversité et Biotechnologies Microbiennes, USR3579, LBBM, Observatoire Océanologique, Banyuls-sur-Mer 66650, France.

I Assiri (I)

Metabolic platform, Biochemistry Laboratory, Team for Childhood, Health and Development, Faculty of Medicine, Cadi Ayyad University, B.P. 7010, Marrakesh, Morocco; Moroccan Association for Inherited Metabolic Diseases, Morocco.

Es Sabir (E)

Metabolic platform, Biochemistry Laboratory, Team for Childhood, Health and Development, Faculty of Medicine, Cadi Ayyad University, B.P. 7010, Marrakesh, Morocco; Moroccan Association for Inherited Metabolic Diseases, Morocco.

K Lafhal (K)

Metabolic platform, Biochemistry Laboratory, Team for Childhood, Health and Development, Faculty of Medicine, Cadi Ayyad University, B.P. 7010, Marrakesh, Morocco; Moroccan Association for Inherited Metabolic Diseases, Morocco.

S Najeh (S)

Metabolic platform, Biochemistry Laboratory, Team for Childhood, Health and Development, Faculty of Medicine, Cadi Ayyad University, B.P. 7010, Marrakesh, Morocco; Moroccan Association for Inherited Metabolic Diseases, Morocco.

M Jakani (M)

Metabolic platform, Biochemistry Laboratory, Team for Childhood, Health and Development, Faculty of Medicine, Cadi Ayyad University, B.P. 7010, Marrakesh, Morocco; Moroccan Association for Inherited Metabolic Diseases, Morocco.

N Imad (N)

Paediatrics' Department, Mohammed VI Hospital University, Marrakesh, Morocco.

A Bourrahouat (A)

Paediatrics' Department, Mohammed VI Hospital University, Marrakesh, Morocco.

I Ait Sab (I)

Paediatrics' Department, Mohammed VI Hospital University, Marrakesh, Morocco.

R Elqadiry (R)

Paediatrics' Department, Mohammed VI Hospital University, Marrakesh, Morocco.

H Nassih (H)

Paediatrics' Department, Mohammed VI Hospital University, Marrakesh, Morocco.

A Outzourit (A)

Internal Medicine Department, Mohammed VI Hospital University, Marrakesh, Morocco.

M Elamiri (M)

Metabolic platform, Biochemistry Laboratory, Team for Childhood, Health and Development, Faculty of Medicine, Cadi Ayyad University, B.P. 7010, Marrakesh, Morocco.

F Maoulainine (F)

Paediatrics' Department, Mohammed VI Hospital University, Marrakesh, Morocco.

N Slitine Elidrissi (N)

Paediatrics' Department, Mohammed VI Hospital University, Marrakesh, Morocco.

F Bennaoui (F)

Paediatrics' Department, Mohammed VI Hospital University, Marrakesh, Morocco.

M Bourous (M)

Paediatrics' Department, Mohammed VI Hospital University, Marrakesh, Morocco.

S Mrhar (S)

Paediatrics' Department, Mohammed VI Hospital University, Marrakesh, Morocco.

L Essaadouni (L)

Internal Medicine Department, Mohammed VI Hospital University, Marrakesh, Morocco.

D Stien (D)

Sorbonne Université, CNRS, Laboratoire de Biodiversité et Biotechnologies Microbiennes, USR3579, LBBM, Observatoire Océanologique, Banyuls-sur-Mer 66650, France.

N Rada (N)

Paediatrics' Department, Mohammed VI Hospital University, Marrakesh, Morocco.

M Bouskraoui (M)

Paediatrics' Department, Mohammed VI Hospital University, Marrakesh, Morocco.

E Houël (E)

Sorbonne Université, CNRS, Laboratoire de Biodiversité et Biotechnologies Microbiennes, USR3579, LBBM, Observatoire Océanologique, Banyuls-sur-Mer 66650, France. Electronic address: emeline.houel@cnrs.fr.

N Fdil (N)

Metabolic platform, Biochemistry Laboratory, Team for Childhood, Health and Development, Faculty of Medicine, Cadi Ayyad University, B.P. 7010, Marrakesh, Morocco; Moroccan Association for Inherited Metabolic Diseases, Morocco. Electronic address: naima.fdil@uca.ac.ma.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH